Related Experiment Video
Updated: Jan 22, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
The Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer
Kazuki Takakura1, Atsushi Kawamura2, Yuichi Torisu2
1Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan. ktakakura@jikei.ac.jp.
Abstract:
Although many diagnostic and therapeutic modalities for pancreatic cancer have been proposed, an urgent need for improved therapeutic strategies remains. Oligonucleotide therapeutics, such as those based on antisense RNAs, small interfering RNA (siRNA), microRNA (miRNA), aptamers, and decoys, are promising agents against pancreatic cancer, because they can identify a specific mRNA fragment of a given sequence or protein, and interfere with gene expression as molecular-targeted agents. Within the past 25 years, the diversity and feasibility of these drugs as diagnostic or therapeutic tools have dramatically increased. Several clinical and preclinical studies of oligonucleotides have been conducted for patients with pancreatic cancer. To support the discovery of effective diagnostic or therapeutic options using oligonucleotide-based strategies, in the absence of satisfactory therapies for long-term survival and the increasing trend of diseases, we summarize the current clinical trials of oligonucleotide therapeutics for pancreatic cancer patients, with underlying preclinical and scientific data, and focus on the possibility of oligonucleotides for targeting pancreatic cancer in clinical implications.
Insights
Oligonucleotide therapeutics offer targeted approaches for pancreatic cancer, addressing the urgent need for better treatments. This review summarizes clinical trials and preclinical data on these promising molecular-targeted agents.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic cancer lacks effective long-term survival therapies.
- Oligonucleotide therapeutics represent a promising molecular-targeted approach.
- These agents can specifically target and interfere with gene expression.
Purpose of the Study:
- To review current clinical trials of oligonucleotide therapeutics for pancreatic cancer.
- To summarize preclinical and scientific data supporting these strategies.
- To explore the clinical implications of oligonucleotides in pancreatic cancer treatment.
Main Methods:
- Literature review of clinical trials and preclinical studies.
- Analysis of oligonucleotide therapeutic modalities (antisense RNA, siRNA, miRNA, aptamers, decoys).
- Focus on molecular targeting mechanisms and gene expression interference.
Main Results:
- Oligonucleotide therapeutics have shown increasing diversity and feasibility.
- Several clinical and preclinical studies have been conducted.
- These agents offer targeted intervention for pancreatic cancer.
Conclusions:
- Oligonucleotide-based strategies are a promising avenue for pancreatic cancer therapy.
- Further research and clinical trials are crucial for advancing treatment options.
- Targeting gene expression offers potential for improved patient outcomes.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Therapeutic Index
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Standard Electrode Potentials
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Cell Potential and Free Energy
Thermodynamics is the branch of physics dealing with the relationship between heat and other forms of energy. In an electrochemical cell, chemical energy is converted into electrical energy.
Thus, a link can be predicted between cell potential, free energy change, and the equilibrium constant for the reaction. Cell potential can also be measured as the oxidant or the reducing strength, and similar acid-base strength measures are reflected in equilibrium...

